Mesoblast
MESO · ASX
$12.28−$0.27 (−2.15%)TodayMarket closed ·
Prev close $12.55
EPS: actual vs estimate
Beat the estimate in 7 of the last 8 quarters, by 43.4% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q4 FY23 | -$0.1252 | -$0.0266 | +78.8% |
| Q3 FY23 | -$0.0479 | -$0.0237 | +50.5% |
| Q2 FY23 | -$0.0603 | -$0.0313 | +48.1% |
| Q1 FY23 | -$0.0479 | -$0.0227 | +52.5% |
| Q4 FY22 | -$0.0479 | -$0.0313 | +34.7% |
| Q3 FY22 | -$0.0383 | -$0.0313 | +18.3% |
| Q2 FY22 | -$0.0479 | -$0.0379 | +20.8% |
| Q1 FY22 | -$0.0287 | -$0.0332 | −15.6% |
Earnings calls
- 2026 Earnings Call
- Special Call - Mesoblast Limited
- MSB.AX - Earnings call Q2 2026
- 2025 Earnings Call
- Mesoblast Limited, H1 2025 Earnings Call, Feb 26, 2025
- Special Call - Mesoblast Limited
- 2024 Earnings Call
- MSB.AX - Earnings call 2 2024
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.